152 related articles for article (PubMed ID: 2581278)
1. Impact of recombinant DNA technology in pharmacology.
Bruno F; Maggi A
Pharmacol Res Commun; 1985 Feb; 17(2):109-21. PubMed ID: 2581278
[No Abstract] [Full Text] [Related]
2. [Genetic technology today and tomorrow. Possibilities and limits from the biological viewpoint].
Starlinger P
Pathologe; 1984 Dec; 5(6):298-304. PubMed ID: 6084244
[No Abstract] [Full Text] [Related]
3. The future for recombinant DNA in medicine: potential for treating genetic diseases.
Baxter JD; Eberhardt NL
Triangle; 1982; 21(4):107-10. PubMed ID: 6927302
[No Abstract] [Full Text] [Related]
4. Scope of DNA cloning and chemical methods in development of chemotherapeutic agents.
Narang SA; Brousseau R; Georges F
Pharmacol Ther; 1984; 26(2):163-89. PubMed ID: 6085403
[No Abstract] [Full Text] [Related]
5. [Medical genetic engineering or molecular biology used in the diagnosis and treatment of disease].
Kaczmarek L
Pol Tyg Lek; 1988 Feb; 43(5):143-7. PubMed ID: 3043397
[No Abstract] [Full Text] [Related]
6. [Impact of molecular biology on medicine].
Velázquez A; Soberón G
Rev Invest Clin; 1986; 38(4):441-7. PubMed ID: 3470862
[No Abstract] [Full Text] [Related]
7. The application of genetically engineered micro-organisms in the production of drugs.
Primrose SB
J Appl Bacteriol; 1986 Aug; 61(2):99-116. PubMed ID: 3533882
[No Abstract] [Full Text] [Related]
8. [Medical use of molecular cloning].
Cabello F
Rev Med Chil; 1984 Jul; 112(7):697-705. PubMed ID: 6083592
[No Abstract] [Full Text] [Related]
9. Microbial biotechnology in industry and medicine.
Keen H
Trans Med Soc Lond; 1981-1982; 98():53-8. PubMed ID: 6765274
[No Abstract] [Full Text] [Related]
10. The effects of modern therapeutics on the human gene pool: changes in the gene pool will likely proceed at a measured pace.
Millard CE
R I Med J (1976); 1980 Nov; 63(11):443-50. PubMed ID: 6934585
[No Abstract] [Full Text] [Related]
11. Recombinant DNA technology.
Emery AE
Lancet; 1981 Dec 19-26; 2(8260-61):1406-9. PubMed ID: 6118771
[No Abstract] [Full Text] [Related]
12. Recombinant DNA techniques in the pharmaceutical industry.
Winther MD
Med Lab Sci; 1985 Oct; 42(4):388-92. PubMed ID: 3866135
[No Abstract] [Full Text] [Related]
13. Gene therapy: how ripe the time ?
Lancet; 1981 Jan; 1(8213):196-7. PubMed ID: 6109862
[No Abstract] [Full Text] [Related]
14. [Genetic engineering--present possibilities and perspectives for its use in medicine].
Srsen S
Cesk Pediatr; 1986 Feb; 41(2):93-7. PubMed ID: 3456854
[No Abstract] [Full Text] [Related]
15. Genetic engineering in mammalian cells.
Anderson WF; Diacumakos EG
Sci Am; 1981 Jul; 245(1):106-8, 113-6, 118-21. PubMed ID: 6168017
[No Abstract] [Full Text] [Related]
16. Genetic manipulation--potential medical and veterinary benefits.
Br Vet J; 1980; 136(5):516-8. PubMed ID: 6164432
[No Abstract] [Full Text] [Related]
17. Industrial microbiology.
Demain AL
Science; 1981 Nov; 214(4524):987-95. PubMed ID: 6946560
[TBL] [Abstract][Full Text] [Related]
18. Into the 21st century. Biotechnology and the pharmaceutical industry in the next ten years.
Drews J
Biotechnology (N Y); 1993 Mar; 11(3):S16-20. PubMed ID: 7763432
[No Abstract] [Full Text] [Related]
19. The impact of molecular biology on the practice of medicine. Part 2. Diagnostics, therapeutics and ethics.
Harrison LC
Med J Aust; 1987 Jul; 147(2):81-9. PubMed ID: 2885728
[No Abstract] [Full Text] [Related]
20. Ethical and social issues in the application of genetic engineering to human beings. Statement to Subcommittee on Investigations and Oversight, Committee on Science and Technology, United States House of Representatives.
Capron AM
Recomb DNA Tech Bull; 1983 Mar; 6(1):3-10. PubMed ID: 6573729
[No Abstract] [Full Text] [Related]
[Next] [New Search]
